EquityRoots
Pharmaceuticals
Healthcare · Pharmaceuticals · Long-term Compounder

Divi's Laboratories Limited

DIVISLAB·6502.5·₹1.73L Cr·Listed 12 Mar 2003
Composite
26
Below median in Pharmaceuticals · Long-term Compounder
Rank10of 12
About DIVISLAB
www.divislabs.com
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
Healthcare
Company description
Founded
1990
Headquarters
Hyderabad, India
CEO / MD
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm · CEO & Whole-Time Director
Major milestone
The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994.
What they do
Activities
generic active pharmaceutical ingredients (APIs)intermediatesnutraceuticals in IndiaNorth AmericaAsiaEurope
Target customers
Not explicitly disclosed
Global footprint
IndiaInternationalUnited StatesEuropeAsia
5 regions mentioned in disclosures
Shareholder breakup
Promoter
51.9%
FII
20.3%+0.2
DII
19.1%
Public
8.6%-0.1
Government
0.1%
As of Mar 2026228006 holders
Read full description

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Sourced from public company disclosures.
About
Divi's Laboratories Limited
IndustryPharmaceuticals & Biotechnology
SectorHealthcare
ClusterPharmaceuticals · Long-term Compounder
Market cap₹1.73L Cr
Listed12 Mar 2003
Price history23 years available
Fundamentals10 years available
Price history
DIVISLAB · monthly close, 2003–2026
+92048%
34.3% CAGR · 23y
6,710.5+661.54 (+10.94%)1Y